Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology

Br J Haematol. 2012 Nov;159(4):427-9. doi: 10.1111/bjh.12052. Epub 2012 Sep 13.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Benzimidazoles / administration & dosage*
  • Benzimidazoles / adverse effects
  • Blood Coagulation / drug effects*
  • Blood Coagulation Tests / methods*
  • Blood Coagulation Tests / standards*
  • Dabigatran
  • Humans
  • Morpholines / administration & dosage*
  • Morpholines / adverse effects
  • Risk Assessment / methods
  • Rivaroxaban
  • Thiophenes / administration & dosage*
  • Thiophenes / adverse effects
  • beta-Alanine / administration & dosage
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Thiophenes
  • beta-Alanine
  • Rivaroxaban
  • Dabigatran